Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -10.10%20.96B | -5.40%94.34B | -3.35%23.32B | 0.00%99.73B | 3.51%26.42B | -8.36%25.98B | -1.28%23.21B | 7.93%24.13B | 17.12%99.73B | 17.67%25.52B |
| Cost of revenue | -10.67%19.29B | -5.79%86.76B | -3.02%21.59B | -1.45%92.09B | 0.36%24.13B | -7.47%23.97B | -2.63%21.73B | 5.07%22.26B | 19.49%93.45B | 19.94%24.04B |
| Gross profit | -3.07%1.67B | -0.75%7.59B | -7.30%1.73B | 21.61%7.64B | 54.70%2.29B | -17.78%2.01B | 23.95%1.48B | 59.91%1.86B | -9.54%6.29B | -10.04%1.48B |
| Operating expense | -16.40%1.64B | -5.73%7.19B | 6.74%1.96B | 8.11%7.63B | 23.03%2.06B | 3.35%1.95B | 0.06%1.78B | 7.10%1.84B | 0.50%7.05B | -7.66%1.68B |
| Staff costs | -2.34%626M | -1.46%2.5B | 0.31%641M | 2.47%2.53B | 8.67%639M | -1.74%621M | 0.79%635M | 2.57%639M | 3.34%2.47B | -2.65%588M |
| Selling and administrative expenses | -20.66%338M | -14.88%1.55B | 0.47%426M | 1.62%1.82B | 30.34%494M | 1.05%483M | -7.89%420M | -11.48%424M | -5.39%1.79B | -14.64%379M |
| -General and administrative expense | -20.66%338M | -14.88%1.55B | 0.47%426M | 1.62%1.82B | 30.34%494M | 1.05%483M | -7.89%420M | -11.48%424M | -5.39%1.79B | -14.64%379M |
| Depreciation and amortization | 13.33%34M | -8.03%126M | -11.76%30M | -9.27%137M | -2.94%33M | -12.50%35M | -12.50%35M | -8.11%34M | 7.86%151M | -10.53%34M |
| -Depreciation | 13.33%34M | -8.03%126M | -11.76%30M | -9.27%137M | -2.94%33M | -12.50%35M | -12.50%35M | -8.11%34M | 7.86%151M | -10.53%34M |
| Other operating expenses | -25.72%644M | -3.77%3.02B | 16.69%867M | 18.81%3.13B | 32.74%896M | 10.10%807M | 5.69%687M | 28.32%743M | 1.78%2.64B | -7.41%675M |
| Operating profit | 113.50%32M | 2,111.11%398M | -1,130.43%-237M | 102.34%18M | 214.72%226M | -88.30%66M | 48.97%-297M | 104.16%23M | -997.14%-768M | -15.20%-197M |
| Net non-operating interest income (expenses) | 102.17%1M | 72.35%-60M | 17.86%-46M | -174.68%-217M | 32.14%-19M | -55.56%-70M | -1,700.00%-72M | -2,700.00%-56M | -1,480.00%-79M | -1,300.00%-28M |
| Non-operating interest income | 12.50%27M | -17.75%139M | -41.46%24M | 0.60%169M | 17.54%67M | -32.43%25M | -2.70%36M | 10.81%41M | 10.53%168M | 32.56%57M |
| Non-operating interest expense | -62.86%26M | -48.45%199M | -27.84%70M | 56.28%386M | 1.18%86M | 15.85%95M | 163.41%108M | 148.72%97M | 57.32%247M | 88.89%85M |
| Net investment income | -117.71%-110M | -71.24%132M | 73.46%621M | -38.88%459M | 27.42%-262M | 914.29%114M | -49.90%249M | -43.08%358M | 46.97%751M | -371.43%-361M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 1,194.24%3.6B | 298,900.00%2.99B | 275.68%278M | 500.00%12M | 225.00%234M | 31M | 1M | -66.52%74M | -99.10%2M |
| Income from associates and other participating interests | 38M | |||||||||
| Special income (charges) | 95.52%-3M | 10.07%-643M | 91.88%-67M | -594.17%-715M | 223.77%151M | -66.67%2M | -4,400.00%-43M | -6,975.00%-825M | 91.73%-103M | 89.90%-122M |
| Less:Other special charges | -102.99%-2M | -35.73%518M | -91.55%67M | 682.52%806M | -122.95%-28M | 66.67%-2M | 4,400.00%43M | 6,708.33%793M | -66.77%103M | -55.31%122M |
| Less:Write off | --5M | 237.36%125M | --0 | ---91M | ---123M | --0 | --0 | --32M | ---- | ---- |
| Other non-operating income (expenses) | -174.19%-23M | 1,400.00%45M | 1,450.00%31M | -97.60%3M | 0.00%-13M | -78.72%10M | -90.00%4M | -96.08%2M | -30.56%125M | -115.85%-13M |
| Income before tax | -102.16%-71M | 2,068.75%3.47B | 755.29%3.28B | -17,500.00%-176M | 113.47%97M | -43.99%354M | -157.14%-126M | -468.38%-501M | 99.75%-1M | 23.40%-720M |
| Income tax | -89.97%111M | 907.88%1.33B | 185.31%1.11B | -108.28%-165M | -179.38%-816M | -40.96%196M | -72.31%67M | -0.77%388M | 157.16%1.99B | 14,785.71%1.03B |
| Net income | -108.37%-182M | 21,420.00%2.13B | 344.38%2.18B | 99.50%-10M | 152.32%915M | -47.51%158M | 33.90%-193M | -250.39%-890M | -68.70%-1.99B | -87.26%-1.75B |
| Net income continuous operations | -108.36%-182M | 19,481.82%2.13B | 344.77%2.18B | 99.45%-11M | 152.23%913M | -47.33%158M | 33.68%-193M | -248.63%-889M | -68.70%-1.99B | -87.35%-1.75B |
| Noncontrolling interests | -61.11%7M | -21.67%47M | 0.00%18M | 3.45%60M | -48.00%13M | 0.00%17M | 12M | 12.50%18M | 114.81%58M | 1,150.00%25M |
| Net income attributable to the company | -108.81%-190M | 3,035.21%2.08B | 337.44%2.16B | 96.54%-71M | 150.76%901M | -50.00%142M | 29.45%-206M | -236.30%-908M | -69.67%-2.05B | -89.64%-1.78B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -108.81%-190M | 3,035.21%2.08B | 337.44%2.16B | 96.54%-71M | 150.76%901M | -50.00%142M | 29.45%-206M | -236.30%-908M | -69.67%-2.05B | -89.64%-1.78B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -108.92%-8.79 | 3,021.47%95.24 | 341.35%98.52 | 96.37%-3.26 | 152.68%40.86 | -49.51%6.23 | 25.02%-9.53 | -246.81%-40.82 | -70.31%-89.7 | -90.33%-77.56 |
| Diluted earnings per share | -108.92%-8.79 | 3,021.47%95.24 | 341.35%98.52 | 96.37%-3.26 | 151.70%40.86 | -49.51%6.23 | 25.02%-9.53 | -246.81%-40.82 | -70.31%-89.7 | -93.93%-79.0266 |
| Dividend per share | 0 | 66.67%20 | 0 | -20.00%12 | -20.00%6 | 0 | -20.00%6 | 0 | 0.00%15 | 50.00%7.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |